116 related articles for article (PubMed ID: 2139592)
1. [Atrial natriuretic factor in liver cirrhosis. Relation to hemodynamic parameters].
Tesar V; Horký K; Jedlicka J; Petrtýl J; Kopecká J; Gregorová I; Marecek Z; Perlík F; Kordac V
Cas Lek Cesk; 1990 Jan; 129(4):117-22. PubMed ID: 2139592
[TBL] [Abstract][Full Text] [Related]
2. Relationships between plasma atrial natriuretic peptide concentrations and hemodynamics and hematocrit in patients with cirrhosis.
Moreau R; Hadengue A; Pussard E; Soubrane O; Sogni P; Gaudin C; Lebrec D
Hepatology; 1991 Dec; 14(6):1035-9. PubMed ID: 1835708
[TBL] [Abstract][Full Text] [Related]
3. [Atrial natriuretic factor, catecholamines and the renin-angiotensin system in cardiac insufficiency. Relation to hemodynamic parameters].
Komajda M; Carayon A; Nguyen JP; Maistre G; Drobinski G; Legrand S; Landault C; Legrand JC; Grosgogeat Y
Arch Mal Coeur Vaiss; 1988 Jul; 81(7):845-53. PubMed ID: 2973293
[TBL] [Abstract][Full Text] [Related]
4. [The effect of dopamine on hemodynamic and hormonal parameters in liver cirrhosis].
Tesar V; Petrtýl J; Jedlicka J; Horký K; Gregorová I; Kopecká J; Marek J; Marecek Z; Kordac V
Cas Lek Cesk; 1990 Apr; 129(17):520-5. PubMed ID: 2140956
[TBL] [Abstract][Full Text] [Related]
5. Estimated central blood volume in cirrhosis: relationship to sympathetic nervous activity, beta-adrenergic blockade and atrial natriuretic factor.
Henriksen JH; Bendtsen F; Gerbes AL; Christensen NJ; Ring-Larsen H; Sørensen TI
Hepatology; 1992 Nov; 16(5):1163-70. PubMed ID: 1358779
[TBL] [Abstract][Full Text] [Related]
6. Increased circulating leptin in alcoholic cirrhosis: relation to release and disposal.
Henriksen JH; Holst JJ; Møller S; Brinch K; Bendtsen F
Hepatology; 1999 Jun; 29(6):1818-24. PubMed ID: 10347125
[TBL] [Abstract][Full Text] [Related]
7. Relationship between hemodynamic changes and blood hormone concentrations after cardiac surgery in children with congenital heart disease.
Alvarez Kindelan A; Pérez Navero JL; Ibarra de la Rosa I; Concha Ruiz M; Montilla López P; Romanos Lezcano A
Crit Care Med; 1994 Nov; 22(11):1754-61. PubMed ID: 7956278
[TBL] [Abstract][Full Text] [Related]
8. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
Bosch J; Kravetz D; Rodes J
Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
[TBL] [Abstract][Full Text] [Related]
9. Plasma substance P levels in patients with liver cirrhosis: relationship to systemic and portal hemodynamics.
Lee FY; Lin HC; Tsai YT; Chang FY; Lu RH; Hou MC; Li CP; Chu CJ; Wang SS; Lee SD
Am J Gastroenterol; 1997 Nov; 92(11):2080-4. PubMed ID: 9362197
[TBL] [Abstract][Full Text] [Related]
10. Atrial natriuretic factor in plasma of patients with arterial hypertension, heart failure or cirrhosis of the liver.
Arendt RM; Gerbes AL; Ritter D; Stangl E; Bach P; Zähringer J
J Hypertens Suppl; 1986 Jun; 4(2):S131-5. PubMed ID: 2941536
[TBL] [Abstract][Full Text] [Related]
11. Hepatic-intestinal disposal of endogenous human alpha atrial natriuretic factor99-126 in patients with cirrhosis.
Henriksen JH; Bendtsen F; Schütten HJ; Warberg J
Am J Gastroenterol; 1990 Sep; 85(9):1155-9. PubMed ID: 2143885
[TBL] [Abstract][Full Text] [Related]
12. Splanchnic hemodynamic factors in cirrhosis with refractory ascites.
Lebrec D; Kotelanski B; Cohn JN
J Lab Clin Med; 1979 Feb; 93(2):301-9. PubMed ID: 429841
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
14. Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: a long-term prospective study.
Piscaglia F; Zironi G; Gaiani S; Mazziotti A; Cavallari A; Gramantieri L; Valgimigli M; Bolondi L
Hepatology; 1999 Jul; 30(1):58-64. PubMed ID: 10385639
[TBL] [Abstract][Full Text] [Related]
15. [Pathophysiologic and clinical relevance of atrial natriuretic factor in patients with cirrhosis of the liver].
Gerbes AL; Arendt R; Xie Y; Knorr HJ; Riedel A; Paumgartner G
Z Kardiol; 1988; 77 Suppl 2():99-103. PubMed ID: 2970181
[TBL] [Abstract][Full Text] [Related]
16. [Relations between ACE inhibition with captopril and atrial natriuretic factor during an acute hemodynamic study].
Mangieri E; Croce CT; Ferraironi A; Salvati A; Sardella GM; Greco C; Avella A; Berni A; Nigri A; Reale A
Cardiologia; 1991 Apr; 36(4):295-8. PubMed ID: 1834331
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of octreotide in patients with hepatic cirrhosis.
McCormick PA; Chin J; Greenslade L; Karatapanis S; Dick R; McIntyre N; Burroughs AK
Hepatology; 1995 May; 21(5):1255-60. PubMed ID: 7737631
[TBL] [Abstract][Full Text] [Related]
18. Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog.
Hollister AS; Rodeheffer RJ; White FJ; Potts JR; Imada T; Inagami T
J Clin Invest; 1989 Feb; 83(2):623-8. PubMed ID: 2521490
[TBL] [Abstract][Full Text] [Related]
19. [Relationships between plasma concentrations of endothelin and the severity of liver cirrhosis].
Hartleb M; Kirstetter P; Moreau R; Soupison T; Pussard E; Hadengue A; Sogni P; Gaudin C; Lebrec D
Gastroenterol Clin Biol; 1994; 18(5):407-12. PubMed ID: 7813855
[TBL] [Abstract][Full Text] [Related]
20. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics.
Tietge UJ; Böker KH; Manns MP; Bahr MJ
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E82-9. PubMed ID: 15010338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
